GlassScriptPhysician profile
Inderpal Sarkaria
NPI 1689827883
$248,035.25
in general payments reported to CMS, 2019-2025
23 companies · $31K in 2025
The $31K reported for 2025 was more than what 95% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76K · 2020: $26K · 2021: $38K · 2022: $45K · 2023: $5,644 · 2024: $26K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $7,807 · Food and Beverage: $6,559 · Education: $5,068 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,165.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,500.00 |
| Travel and Lodging | $7,806.61 |
| Food and Beverage | $6,558.88 |
| Education | $5,068.49 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $178,401.86 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Stryker Corporation | $36,363.06 | 2021-2025 | 1788, Spy-Phi System |
| Ethicon Endo-Surgery INC. | $13,345.00 | 2025 | |
| Ethicon INC. | $6,417.72 | 2019-2023 | Monarch Platform |
| Medtronic, INC. | $6,410.85 | 2022-2025 | Signia, Signet, Ligasure |
| Medical Device Business Services, INC. | $2,215.26 | 2022-2025 | |
| Boston Scientific Corporation | $1,124.25 | 2019-2025 | General - Hemostasis |
| Pinnacle Biologics, INC | $1,096.22 | 2019-2023 | Photofrin |
| Covidien LP | $789.96 | 2019-2020 | |
| On Target Laboratories, INC | $670.87 | 2024-2025 | Cytalux |
| Biom'Up Sa | $151.98 | 2019 | |
| Bard Access Systems, INC. | $140.48 | 2019 | |
| Davol INC. | $138.36 | 2023-2024 | Progel Applicator Spray Tips, Phasix Mesh |
| Pulmonx Corporation | $127.77 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Ethicon US, LLC | $120.00 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veran Medical Technologies, INC. | $113.79 | 2019-2020 | |
| Erbe USA INC | $82.21 | 2025 | Vio3cryo2 |
| Activ Surgical, INC. | $72.23 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Atricure, INC. | $65.21 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Edwards Lifesciences Corporation | $61.31 | 2025 | Mitris Resilia Mitral Valve |
| Galvanize Therapeutics, INC | $34.37 | 2025 | Aliya System |
| Depuy Synthes Sales INC. | $24.00 | 2025 | Matrixrib |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inderpal Sarkaria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.